Published by
@ShahidNShah
@ShahidNShah
February 13 to February 15, 2024
Hilton Boston Back Bay, 40 Dalton Street, Boston, Massachusetts, 02115, United States
In spite of challenges in delivering RNAi therapeutics beyond the liver and scaling up manufacturing, the 5th RNAi-Based Therapeutics Summit, returning to Boston in February 2024, promises fresh insights. This event will feature a revamped pre-conference workshop highlighting innovative approaches to target untreatable areas. Leading industry figures from Alnylam Pharmaceuticals, Dicerna Pharmaceuticals, Transcode Therapeutics, Sirnaomics, and OliX Pharmaceuticals will convene to tackle key hurdles in RNAi therapy development. Through data-driven presentations and interactive sessions, this dedicated gathering aims to expedite RNAi therapeutics' journey to clinical application and approval. Scheduled from Tue, 13 Feb 2024, at 08:00 to Thu, 15 Feb 2024, at 16:00.
Read on rnaibased-therapeutics
Continue reading at rnaibased-therapeutics.com
February 13 to February 15, 2024
Hilton Boston Back Bay, 40 Dalton Street, Boston, Massachusetts, 02115, United States
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Media LLC. All Rights Reserved.
Built on Apr 26, 2024 at 6:14am